Carlsquare advised SHS on the sale of puracon to Klingel
Klingel medical metal, based in Pforzheim, acquires 100 percent of the shares in puracon GmbH from SHS, a medical technology investor based in Tübingen. Klingel is adding sterile packaging services including validations to its value chain by acquiring the Medtech specialist based in Rosenheim.
SHS Gesellschaft für Beteiligungsmanagement mbH, based in Tübingen, is selling its shares in puracon GmbH to Klingel medical metal GmbH, a portfolio company of IK Investment Partners. With 600 employees, Klingel Group is one of the leading companies in the field of precision machining of high-strength materials such as stainless steel and titanium for the production of medical technology products made of metal. The purchase of puracon allows Klingel to benefit from valuable synergies as contract developer, manufacturer and packer and offer its worldwide medical technology customers a complete range of services based on the “one-stop-shop” principle. This is already the third acquisition for Klingel since IK Investment Partners acquired a stake in 2018.
SHS Gesellschaft für Beteiligungsmanagement mbH, based in Tübingen, has been active as an investor in the field of medical technology and life sciences for more than two decades. This makes SHS one of the most experienced investment companies in this sector currently investing from SHS fund V.
At the end of 2015, SHS took a stake in puracon GmbH based in Rosenheim. As a full-service partner for the medtech industry, puracon offers efficient packaging and validation solutions for medical technology products: primarily implants and instruments. Thus, puracon is part of the validated process chain of implants and the final station before the sterile product is used for patients in the hospital.
Sascha Alilovic, Managing Partner of SHS, says: “With Klingel medical metal, puracon is able to continue to pursue a targeted course of growth. Klingel thinks about the long-term. The company has been in the market since 1986 and is today one of the leading suppliers in its field. Our goal was to support puracon on the road to profitable growth. We’ve achieved this, and now it’s time to ignite the next stage – and Klingel is the perfect partner for this.”
Ralf Petrawitz, Managing Partner and CEO of Klingel, plans to significantly expand his offering for medical technology customers worldwide on the basis of this acquisition. “puracon is a very good addition to an already extensive product range for our demanding customers from the medical technology sector. As a result, we are now able to offer services in the field of validation and packaging within the Klingel Group. These factors enable us to specifically strengthen our competitive position and make us fit for the future.”
Ruth Gessner, Managing Director of puracon, is also pleased with this development: “Together with SHS, we as a puracon team have been able to significantly expand our customer base over the last five years, thereby generating strong growth. With Klingel Group, we will take the next step and achieve synergies that will benefit both our customers and our employees. We look forward to working with them.”
Carlsquare acted as the exclusive sell-side advisor for the Tübingen SHS Gesellschaft für Beteiligungsmanagement mbH.